CVR: 39724758
GlyProVac ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Anders Boysen and Ann Zahle Andersen. The company's owners include Bente Kristiansen, Rossi Finans ApS and I/S Rødeledsvej. The company has 3 employees. In 2025, the company reported a gross profit of DKK -2,128,863 and a net result of DKK -5,168,999 compared with DKK -3,014,952 the year before. Equity amounted to DKK -831,720.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er udvikle, kommercialisere, fremstille og sælge bakterielle vacciner.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -2.1 mio. | -5.2 mio. | 4.6 mio. | -832 t. | 6 | |
| 2024 | -577 t. | -3 mio. | 4.4 mio. | -654 t. | 5 | |
| 2023 | -815 t. | -2.9 mio. | 5.5 mio. | 852 t. | 4 | |
| 2022 | 1.3 mio. | -633 t. | 12.2 mio. | 5 mio. | 4 | |
| 2021 | 993 t. | -487 t. | 9.5 mio. | 2.4 mio. | 3 | |
| 2020 | 1.1 mio. | -699 t. | 3.7 mio. | 672 t. | 4 | |
| 2019 | 145 t. | -918 t. | 2.6 mio. | 1.4 mio. | 2 |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
As of June 11, 2026, Ann Zahle Andersen has joined the board of directors of GlyProVac ApS.
As of June 10, 2026, Ann Zahle Andersen has left the board of directors of GlyProVac ApS.
As of May 19, 2026, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.
As of May 1, 2026, Bente Kristiansen is registered as an owner of GlyProVac ApS with an ownership share of 10%.
GlyProVac ApS has published its annual report for 2025. Gross profit came to DKK -2,128,863, and the net result was DKK -5,168,999.
GlyProVac ApS has published its annual report for 2024. Gross profit came to DKK -577,426, and the net result was DKK -3,014,952.
GlyProVac ApS has published its annual report for 2023. Gross profit came to DKK -814,748, and the net result was DKK -2,871,688.
As of October 5, 2023, Kirsten Winther has joined the board of directors of GlyProVac ApS.
As of October 5, 2023, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.
As of October 4, 2023, Kirsten Winther has left the board of directors of GlyProVac ApS.
As of October 4, 2023, Tommi Petteri Kainu has left the board of directors of GlyProVac ApS.
As of September 28, 2023, Rossi Finans ApS is registered as an owner of GlyProVac ApS with an ownership share of 10%.
GlyProVac ApS has published its annual report for 2022. Gross profit came to DKK 1,321,135, and the net result was DKK -633,455.
As of March 1, 2022, Allan Rosetzsky has joined the board of directors of GlyProVac ApS.
As of March 1, 2022, Anders Boysen has left the board of directors of GlyProVac ApS.
As of March 1, 2022, I/S Rødeledsvej is registered as an owner of GlyProVac ApS with an ownership share of 5%.
As of March 1, 2022, GlycoPharma Holding ApS is registered as an owner of GlyProVac ApS with an ownership share of 33%.
As of January 1, 2022, Tommi Petteri Kainu has joined the board of directors of GlyProVac ApS.
GlyProVac ApS has published its annual report for 2021. Gross profit came to DKK 993,453, and the net result was DKK -487,049.
As of August 29, 2021, Willem Adriaan de Jongh has joined the board of directors of GlyProVac ApS.
GlyProVac ApS has published its annual report for 2020. Gross profit came to DKK 1,050,949, and the net result was DKK -698,589.
GlyProVac ApS has published its annual report for 2019. Gross profit came to DKK 145,314, and the net result was DKK -917,733.
As of January 29, 2019, Kirsten Winther has joined the board of directors of GlyProVac ApS.
As of January 25, 2019, Peter Smedegaard has left the board of directors of GlyProVac ApS.
As of July 3, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GlyProVac ApS.
As of July 3, 2018, Peter Smedegaard has joined the board of directors of GlyProVac ApS.
As of July 3, 2018, Anders Boysen has joined the board of directors of GlyProVac ApS.
As of July 3, 2018, Ann Zahle Andersen has joined the board of directors of GlyProVac ApS.
As of July 3, 2018, Anders Boysen is registered as adm. dir. of GlyProVac ApS.
As of July 3, 2018, Ann Zahle Andersen is registered as director of GlyProVac ApS.
GlyProVac ApS was founded on July 3, 2018.
Companies in the same industry and area